東材科技(601208.SH):管理人已將勝通光科的股權變更登記至公司名下
格隆匯 6 月 30日丨東材科技(601208.SH)公佈,2020年6月30日,管理人根據山東省東營市中級人民法院批准的《山東勝通集團股份有限公司等十一家公司合併重整計劃》,已將勝通光科的股權變更登記至公司名下。此次股權變更登記完成後,公司持有勝通光科的100%股權,勝通光科成為公司的全資子公司。
2020年6月30日,公司通過轉賬匯款方式將剩餘的勝通光科股權收購款支付給管理人,支付金額為人民幣4.96億元。截止公告披露之日,公司已累計支付勝通光科的股權收購款為人民幣5.56億元,此次收購勝通光科的股權收購款已全部支付完畢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.